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doi:10.1016/j.ejvs.2011.05.011Abstract Diffuse dermal angiomatosis (DDA) is characterized clinically by painful erythema-
tous lesions with ulcers and histologically by a benign, diffuse, and self-limited proliferation of
tiny blood vessels in the superficial layers of the reticular dermis. Here we describe a case of
DDA with leg ulcer. Erythematous lesions presented around the ulcer and angiogram revealed
an occlusion of the superficial femoral artery. The erythematous lesions disappeared after
revascularization. Although DDA is extremely rare, early correction of the ischemia in the
peripheral artery should be taken into consideration.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Diffuse dermal angiomatosis (DDA) is a rare, acquired
cutaneous, reactive, vascular disorder that was first
described in 1994.1 DDA is a benign vascular proliferation
characterized by poorly circumscribed, erythematous to
violaceous lesions with frequent ulceration. Histologically,
diffuse and mostly extravascular interstitial proliferation of
CD31-positive endothelial cells and myofibroblasts are
present within the reticular dermis in DDA cases.44 29 8890; fax: þ81 744 25
@live.jp (K. Morimoto).
ty for Vascular Surgery. PublisheCase Report
A65-year-oldmalewith a history of hypertension and smoking
(smoking a pack per day for 40 years) presented with
a 1-month history of a painful, erythematous lesion on the
right lower extremity (Fig. 1A,B). Over the past 6 months, he
noticed progressive intermittent claudication of the right calf
after walking approximately 300 m. However, the walking
distancewithoutpainhadgradually shortened,anddecreased
to 50 m at the first admission. He had non-palpable pulses in
the rightpopliteal, posterior tibial, anddorsal pedalpositions.
In addition, the right ankle-brachial index was unmeasurable
and the right toe systolic pressure was 20 mmHg.
After 1 week, he developed an ulceration on the lesion.
Prednisolone (10 mg/day) was administrated, as isd by Elsevier Ltd. All rights reserved.
Figure 1 A: Erythematous lesion on the front right leg with purpuric lesion. B: The back of the right leg. C: Leg ulceration
progressed. D, E: Histopathologic examination demonstrates a diffuse proliferation of benign endothelial cells in the papillary and
reticular dermis. There is scant formation of small vascular lumina with occasional extravasating erythrocytes and no evidence of
cholesterol emboli or vasculitis (A and B, hematoxylineeosin stain; original magnification: A, 40; B, 400). F: Positive immu-
nohistochemical staining using anti-CD31 antibody confirms the endothelial nature of the infiltrate (original magnification 400).
382 K. Morimoto et al.commonly prescribed in patients with vasculitis. A blood
test was performed, and a biopsy was obtained from the
central, non-ulcerated region of the lesion. Values of
antinuclear body, rheumatoid factor, lupus anticoagulant,
anticardiolipin body, cryoglobulin, cytoplasmic anti-
neutrophil antibody (C-ANCA), cytoplasmic perinuclearFigure 2 A: CT angiography showed the right superficial femo
revealed an occlusion of the right superficial femoral artery. C, D:
tibial artery. E: Several stenotic lesions were noted after thromboly
femoral artery.anti-neutrophil cytoplasmic antibodies (P-ANCA), fibrin
degradation products (FDP), and D-dimer were normal.
Histopathologic examination demonstrated a dense prolif-
eration of endothelial cells (Fig. 1DeF). Staining was
negative for human herpes virus 8. The clinical and path-
ological findings were consistent with DDA, and thereforeral artery occlusion and collateral blood flow. B: Angiogram
Distal run off was well seen despite partial stenosis at anterior
sis. F: Endovascular stent was deployed distal to the superficial
Diffuse Dermal Angiomatosis 383prednisolone was reduced and stopped. A subsequent CT
angiography showed right superficial femoral artery occlu-
sion and collateral blood flow (Fig. 2A). Doppler ultraso-
nography showed the presence of thrombosis at the
superficial femoral artery.
The patient’s ulcer continued to grow (Fig. 1C) and he
was admitted 4 weeks after presentation. DSA before the
procedure showed a 20-cm-long occlusion of the right
superficial femoral artery from the orifice (Fig. 2BeD). He
was diagnosed with acute thrombosis, and 12  104 units of
urokinase were infused from the catheter and recanaliza-
tion was obtained. Residual thrombi were aspirated using
the Thrombaster III (Kaneka Medix, Osaka, Japan).
However, several stenotic lesions were noted (Fig. 2E), and
therefore balloon angioplasty and implantation of
a 6  120 mm Luminexx stent (Bard Peripheral, Vascular,
Tempe, AZ) were performed (Fig. 2F). The right ankle-
brachial index increased to 1.01 and toe systolic pressure to
120 mmHg. Following the revascularization, the patient
was prescribed oral aspirin (100 mg/day) and sarpogrelate
hydrochloride (300 mg/day). Five weeks after the revas-
cularization procedure, the erythematous lesions on the
right lower extremity disappeared and the skin ulcer region
was reduced.
Discussion
To date, 7 cases of DDA with atherosclerosis including our
case have been reported,1e5 with similar clinical and
histopathological findings. All patients presented with
erythematous or violaceous lesion with ulcer and had
arterial stenosis. All underwent a revascularization proce-
dure, which resulted in the healing of the erythematous
lesion and skin ulcer region within 10 weeks.
The 6-month-old intermittent claudication and the
presence of collateral circulation with several stenotic
lesions on the angiogram suggested that leg ischemia was
caused by chronic arterial disease. Moreover, if prolifera-
tion of endothelial cells resulted in chronic ischemia, the
patient would demonstrate necrosis, but not proliferation
of endothelial cells, with acute ischemia. The age of the
thrombus in the superficial femoral artery is unknown, but
based on the fact that lysis was successful, it is unlikely to
be older than 2e3 weeks. It is reasonable to assume that
stenosis was present prior to the acute event, and acute
widespread thrombosis at the superficial femoral artery
might have the potential to attenuate the rapid progressionof the ulcer. Thus, DDA might be associated with severe
ischemia, because all published cases of DDA-related
atherosclerosis had severe ischemia with ulcerations.
Furthermore, we found that the emergence of DDA was
synchronized with the deterioration of ischemia. DDA might
presage the emergence of ischemic ulcer.
In summary, we described a case of DDA-related severe
peripheral vascular atherosclerosis. Successful revasculari-
zation facilitated the healing of the DDA in our patient, as
well as in all published cases. DDA might be a premonitory
sign of ischemic ulcer. When DDA is found in patients with
peripheral vascular disease, early correction of the
ischemia should be taken into the consideration.Acknowledgments
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